P-279: Efficacy, safety, and pharmacokinetics of iberdomide plus dexamethasone in patients with relapsed/refractory multiple myeloma by renal function: a subgroup analysis of the CC-220-MM-001 trial
Title:
P-279: Efficacy, safety, and pharmacokinetics of iberdomide plus dexamethasone in patients with relapsed/refractory multiple myeloma by renal function: a subgroup analysis of the CC-220-MM-001 trial
Author:
van de Donk, Niels W.C.J. Raab, Marc S. Besemer, Britta Siegel, David S. Anwer, Faiz Lipe, Brea White, Darrell Khan, Abdullah Pianko, Matthew J. Cheng, Yiming Chen, Lu Lin, Hongxia Maciag, Paulo Emerson, Joshua Amin, Alpesh Lonial, Sagar